Maarten Ooms

8PUBLICATIONS
30CO-AUTHORS
Pharmaceutical delivery technologiesReaction engineering (excl. nuclear reactions)Radiation therapyInstruments and techniquesPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 22, 2025
Preclinical characterization of 3p-C-DEPA-NCS and 3p-C-DEPA-TFP-PEG4 as potential Actinium-225 bifunctional chelators using DOTA-NCS and macropa-NCS as benchmarks.

Jessica Pougoue Ketchemen, Stephen Ahenkorah, Emmanuel Nwangele

|Apr 13, 2023
Preclinical Evaluation of [155/161Tb]Tb-Crown-TATE-A Novel SPECT Imaging Theranostic Agent Targeting Neuroendocrine Tumours.

Luke Wharton, Scott W McNeil, Helen Merkens

|Dec 23, 2022
Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [153Sm]Sm-DOTA-TATE.

Koen Vermeulen, Michiel Van de Voorde, Charlotte Segers

|Apr 18, 2022
Bifunctional chelators for radiorhenium: past, present and future outlook.

Diana R Melis, Andrew R Burgoyne, Maarten Ooms

Pageof 2